Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Kymera Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 4 Mainolfi Nello (CEO) has filed a Form 4 on Kymera Therapeutics, Inc.
Txns: Exercised 12,000 options to buy @ $2.08, valued at $25k
06/02/2023 4 Jacobs Bruce N. (CFO) has filed a Form 4 on Kymera Therapeutics, Inc.
Txns: Exercised 10,000 options to buy @ $2.08, valued at $20.8k
05/22/2023 4 Chadwick Jeremy G (COO) has filed a Form 4 on Kymera Therapeutics, Inc.
Txns: Granted 33,333 shares @ $0
Granted 200,000 options to buy @ $29.64, valued at $5.9M
05/22/2023 3 Chadwick Jeremy G (COO) has filed a Form 3 on Kymera Therapeutics, Inc.
01/13/2023 4 BVF PARTNERS L P/IL (Director) has filed a Form 4 on Kymera Therapeutics, Inc.
Txns: Bought 10,961 shares @ $29.8869, valued at $327.6k
Bought 11,149 shares @ $29.8869, valued at $333.2k
Bought 2,985 shares @ $31.2426, valued at $93.3k
Bought 15,912 shares @ $31.2426, valued at $497.1k
01/13/2023 4 Booth Bruce (Director) has filed a Form 4 on Kymera Therapeutics, Inc.
Txns: Sold 21,683 shares @ $29.96, valued at $649.6k
Sold 6,071 shares @ $29.96, valued at $181.9k
Sold 77,128 shares @ $30.29, valued at $2.3M
Sold 21,592 shares @ $30.29, valued at $654k
01/13/2023 4 Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Kymera Therapeutics, Inc.
Txns: Sold 21,683 shares @ $29.96, valued at $649.6k
Sold 6,071 shares @ $29.96, valued at $181.9k
Sold 77,128 shares @ $30.29, valued at $2.3M
Sold 21,592 shares @ $30.29, valued at $654k
01/04/2023 4 Chiniara Ellen (Chief Legal Officer) has filed a Form 4 on Kymera Therapeutics, Inc.
Txns: Granted 37,500 shares @ $0
Granted 225,000 options to buy @ $24.84, valued at $5.6M
01/04/2023 3 Chiniara Ellen (Chief Legal Officer) has filed a Form 3 on Kymera Therapeutics, Inc.
12/16/2022 4 Booth Bruce (Director) has filed a Form 4 on Kymera Therapeutics, Inc.
Txns: Sold 112,819 shares @ $30.28, valued at $3.4M
Sold 101,189 shares @ $31.44, valued at $3.2M
Sold 54,737 shares @ $32.33, valued at $1.8M
Sold 13,997 shares @ $33.34, valued at $466.7k
Sold 13,335 shares @ $34.02, valued at $453.7k
Sold 31,584 shares @ $30.28, valued at $956.4k
Sold 28,329 shares @ $31.44, valued at $890.7k
Sold 15,324 shares @ $32.33, valued at $495.4k
Sold 3,919 shares @ $33.34, valued at $130.7k
Sold 3,733 shares @ $34.02, valued at $127k
Sold 2,561 shares @ $30, valued at $76.8k
12/16/2022 4 Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Kymera Therapeutics, Inc.
Txns: Sold 112,819 shares @ $30.28, valued at $3.4M
Sold 101,189 shares @ $31.44, valued at $3.2M
Sold 54,737 shares @ $32.33, valued at $1.8M
Sold 13,997 shares @ $33.34, valued at $466.7k
Sold 13,335 shares @ $34.02, valued at $453.7k
Sold 31,584 shares @ $30.28, valued at $956.4k
Sold 28,329 shares @ $31.44, valued at $890.7k
Sold 15,324 shares @ $32.33, valued at $495.4k
Sold 3,919 shares @ $33.34, valued at $130.7k
Sold 3,733 shares @ $34.02, valued at $127k
Sold 2,561 shares @ $30, valued at $76.8k
12/08/2022 4 Mainolfi Nello (CEO) has filed a Form 4 on Kymera Therapeutics, Inc.
Txns: Exercised 10,000 options to buy @ $2.08, valued at $20.8k
11/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/03/2022 4 Sandor Victor (Director) has filed a Form 4 on Kymera Therapeutics, Inc.
Txns: Granted 24,000 options to buy @ $30.92, valued at $742.1k
11/03/2022 3 Sandor Victor (Director) has filed a Form 3 on Kymera Therapeutics, Inc.
10/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/17/2022 4 Jacobs Bruce N. (CFO) has filed a Form 4 on Kymera Therapeutics, Inc.
Txns: Exercised 10,000 options to buy @ $2.08, valued at $20.8k
10/17/2022 4 Mainolfi Nello (CEO) has filed a Form 4 on Kymera Therapeutics, Inc.
Txns: Exercised 32,056 options to buy @ $2.08, valued at $66.7k
Exercised 27,676 options to buy @ $2.08, valued at $57.6k
08/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/08/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy